The studies were performed to investigate the physiological characteristics of non-obese diabetic (NOD) mice treated with FTY720. At the age of 12 weeks, each mouse was fed with FTY720 or physiological saline once a day for 10 weeks running, and their blood glucose, weight, anti-GAD antibody and organ indexes were determined. No mouse in group FTY720 (NOD mice treated with FTY720) showed diabetic symptoms. The average content of serum anti-GAD antibody in group FTY720 decreased 48.75% (P < 0.01). It was concluded that the spleen, kidney and liver of NOD mice treated with FTY720 shriveled significantly in the progression of diabetes (P < 0.01 or P < 0.05). The body weight of group FTY720 mice was slightly lower than that of the model control...
<p>For assessing insulin sensitivity, fasting blood glucose (A), fasting serum insulin level (B) and...
<p>(A,B) Fasting blood glucose (A) and insulin levels (B) in male non-progressing mice 30 weeks of a...
<p>Newly diagnosed and established diabetic NOD mice were treated with AG490 (i.p, 1 mg/mouse) witho...
<p>A: FPE decreased blood glucose in the experimental diabetic mice. B: FPE increased body weights i...
<p>Male control and DJ-1 KO mice at 12–13 weeks of age were treated with 40 mg STZ/kg body weight on...
<p>A. Blood glucose levels of control and diabetic mice are shown as a function of time after the in...
<p><i>db/m</i>, nondiabetic control mice; <i>db/db</i>, untreated diabetic mice; <i>db/db</i>+0.1 da...
<p>STZ induced type 1 diabetic FVB mice were intraperitoneally treated with or without nm-aFGF (10 µ...
<p>(A, D) No significant change was observed on blood glucose levels during the OGTT between vehicle...
<p>The type 2 diabetic mouse model was established by a combination of a HFD and STZ treatment. C57B...
<p>(<b>A</b>) RBG was examined weekly during ZBPYR administration. ZBPYR significantly reduced gluco...
<p>Female NOD mice were analyzed every two weeks from age 4–24 weeks (n = 3–9 per group). Weights ar...
<p><b>a</b>, Body weights of male <i>db/db</i> mice treated with vehicle (empty diamonds) or P1736 ...
<p>The WT and <i>db/db</i> mice were fed a standard laboratory diet for 9 weeks. Body weight and the...
<p>Non-diabetic female NOD mice (n=33-34/group) at 12 weeks of age were administered ISO-092 or vehi...
<p>For assessing insulin sensitivity, fasting blood glucose (A), fasting serum insulin level (B) and...
<p>(A,B) Fasting blood glucose (A) and insulin levels (B) in male non-progressing mice 30 weeks of a...
<p>Newly diagnosed and established diabetic NOD mice were treated with AG490 (i.p, 1 mg/mouse) witho...
<p>A: FPE decreased blood glucose in the experimental diabetic mice. B: FPE increased body weights i...
<p>Male control and DJ-1 KO mice at 12–13 weeks of age were treated with 40 mg STZ/kg body weight on...
<p>A. Blood glucose levels of control and diabetic mice are shown as a function of time after the in...
<p><i>db/m</i>, nondiabetic control mice; <i>db/db</i>, untreated diabetic mice; <i>db/db</i>+0.1 da...
<p>STZ induced type 1 diabetic FVB mice were intraperitoneally treated with or without nm-aFGF (10 µ...
<p>(A, D) No significant change was observed on blood glucose levels during the OGTT between vehicle...
<p>The type 2 diabetic mouse model was established by a combination of a HFD and STZ treatment. C57B...
<p>(<b>A</b>) RBG was examined weekly during ZBPYR administration. ZBPYR significantly reduced gluco...
<p>Female NOD mice were analyzed every two weeks from age 4–24 weeks (n = 3–9 per group). Weights ar...
<p><b>a</b>, Body weights of male <i>db/db</i> mice treated with vehicle (empty diamonds) or P1736 ...
<p>The WT and <i>db/db</i> mice were fed a standard laboratory diet for 9 weeks. Body weight and the...
<p>Non-diabetic female NOD mice (n=33-34/group) at 12 weeks of age were administered ISO-092 or vehi...
<p>For assessing insulin sensitivity, fasting blood glucose (A), fasting serum insulin level (B) and...
<p>(A,B) Fasting blood glucose (A) and insulin levels (B) in male non-progressing mice 30 weeks of a...
<p>Newly diagnosed and established diabetic NOD mice were treated with AG490 (i.p, 1 mg/mouse) witho...